Abstract | OBJECTIVE: METHODS: By using cluster randomization, classrooms of 744 Mongolian schoolchildren were randomly assigned to different treatments in winter (January-March). This analysis focused on a subset of 247 children who were assigned to daily ingestion of unfortified regular milk (control; n = 104) or milk fortified with 300 IU of vitamin D(3) (n = 143). This comparison was double-blinded. The primary outcome was the number of parent-reported ARIs over the past 3 months. RESULTS: At baseline, the median serum 25( OH)D level was 7 ng/mL (interquartile range: 5-10 ng/mL). At the end of the trial, follow-up was 99% (n = 244), and the median 25( OH)D levels of children in the control versus vitamin D groups was significantly different (7 vs 19 ng/mL; P < .001). Compared with controls, children receiving vitamin D reported significantly fewer ARIs during the study period (mean: 0.80 vs 0.45; P = .047), with a rate ratio of 0.52 (95% confidence interval: 0.31-0.89). Adjusting for age, gender, and history of wheezing, vitamin D continued to halve the risk of ARI (rate ratio: 0.50 [95% confidence interval: 0.28-0.88]). Similar results were found among children either below or above the median 25( OH)D level at baseline (rate ratio: 0.41 vs 0.57; P(interaction) = .27). CONCLUSIONS:
|
Authors | Carlos A Camargo Jr, Davaasambuu Ganmaa, A Lindsay Frazier, Franca F Kirchberg, Jennifer J Stuart, Ken Kleinman, Nyamjav Sumberzul, Janet W Rich-Edwards |
Journal | Pediatrics
(Pediatrics)
Vol. 130
Issue 3
Pg. e561-7
(Sep 2012)
ISSN: 1098-4275 [Electronic] United States |
PMID | 22908115
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Vitamin D
- 25-hydroxyvitamin D
|
Topics |
- Acute Disease
- Animals
- Child
- Dietary Supplements
- Double-Blind Method
- Food, Fortified
- Humans
- Milk
- Mongolia
- Respiratory Tract Infections
(blood, prevention & control)
- Vitamin D
(administration & dosage, analogs & derivatives, blood)
- Vitamin D Deficiency
(complications, therapy)
|